Ligand validation:8A2V

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 8A2V designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8A2V_FMN_A_1001	84%	63%	0.078	0.94	0.76	0.65	-	-	0	0	100%	1
6QQH_FMN_A_1001	99%	38%	0.047	0.982	1.23	1.19	3	4	0	0	100%	1
7QF3_FMN_AAA_201	98%	61%	0.061	0.987	0.79	0.71	-	-	0	0	100%	0.7
6GPU_FMN_A_1001	98%	53%	0.058	0.982	0.99	0.85	3	2	0	0	100%	1
6QSA_FMN_A_1001	97%	30%	0.067	0.98	1.45	1.35	4	6	0	0	100%	0.7
6QQI_FMN_A_1001	93%	31%	0.078	0.974	1.36	1.39	4	6	0	0	100%	0.5
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.